Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0081
+0.0001 (1.25%)
At close: Mar 5, 2026
Petros Pharmaceuticals Employees
Petros Pharmaceuticals had 18 employees as of December 31, 2024. The number of employees decreased by 3 or -14.29% compared to the previous year.
Employees
18
Change (1Y)
-3
Growth (1Y)
-14.29%
Revenue / Employee
$284,002
Profits / Employee
-$3,127,104
Market Cap
343.22K
Employees Chart
Petros Pharmaceuticals News
- 9 months ago - Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position - Accesswire
- 10 months ago - Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets - Accesswire
- 10 months ago - Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer - Accesswire
- 10 months ago - Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - Accesswire
- 11 months ago - Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches - Accesswire
- 11 months ago - Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms - Accesswire
- 1 year ago - Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - Accesswire
- 1 year ago - Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study - Accesswire